Sign in

CIK 0001635088 · Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
operating
EIN
981173944
Phone
441-295-5950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,719,562
in 13 filings, $45.5M under 10b5-1 plans

Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Venker Eric −$43.7M President & Immunovant CEO sold 59% of stake
  2. Sukhatme Mayukh −$27.7M President & CIO sold 4% of stake
  3. Pulik Richard −$12.5M CFO sold 57% of stake
  4. Fitzgerald Meghan −$1.0M Director sold 41% of stake
  5. Epperly Melissa B, −$837K Director sold 60% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-16 Sukhatme Mayukh President & CIO Shares withheld for taxes −19,976 $33.53 $670K 18,563,884
2026-10-16 Gline Matthew CEO Shares withheld for taxes −34,638 $33.53 $1.2M 16,549,136
2026-10-01 Epperly Melissa B, Director Option exercise 10b5-1 +17,750 $4.46 $79K 32,704
2026-10-01 Epperly Melissa B, Director Sale 10b5-1 −16,850 $36.08 $608K 15,854
2026-10-01 Epperly Melissa B, Director Sale 10b5-1 −900 $36.57 $33K 14,954
2026-10-01 Epperly Melissa B, Director Option exercise · Stock Option (Right to Buy) 10b5-1 −17,750 151,416
2026-09-30 Sukhatme Mayukh President & CIO Shares withheld for taxes −46,879 $36.57 $1.7M 18,583,860
2026-09-30 Venker Eric President & Immunovant CEO Option exercise 10b5-1 +200,000 $3.85 $770K 1,799,154
2026-09-30 Venker Eric President & Immunovant CEO Sale 10b5-1 −200,000 $36.62 $7.3M 1,599,154
2026-09-30 Venker Eric President & Immunovant CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −200,000 3,644,834
2026-09-30 Gline Matthew CEO Shares withheld for taxes −76,171 $36.57 $2.8M 16,583,774
2026-09-30 Torti Frank President and Vant Chair Shares withheld for taxes +40,309 $36.57 $1.5M 13,495,893
2026-09-20 Pulik Richard CFO Shares withheld for taxes −2,129 $39.77 $85K 269,681
2026-09-20 Humes Jennifer Chief Accounting Officer Shares withheld for taxes −3,880 $39.77 $154K 106,419
2026-09-16 Epperly Melissa B, Director Grant or award +5,054 14,954
2026-09-16 Epperly Melissa B, Director Grant or award · Stock Option (Right to Buy) +10,531 10,531
2026-09-16 Gold Daniel Allen Director Grant or award +5,054 8,965,815
2026-09-16 Gold Daniel Allen Director Grant or award · Stock Option (Right to Buy) +10,531 10,531
2026-09-16 Oren Ilan Director Grant or award +5,054 123,680
2026-09-16 Oren Ilan Director Grant or award · Stock Option (Right to Buy) +10,531 10,531

Page 3 of 29 · 570 trades